What we do

Both Catalonia.health member companies are joining forces to offer a comprehensive consultancy, digital transformation and regulatory compliance service to Life Sciences companies.

With this appointment, the organisation embarks on a new strategic phase focused on growing the association, strengthening connections between member companies and creating more value to its members.

CONNECTA Therapeutics has closed a €3.1 million round led by new investor Clave Capital, with support from existing backers Inveready, CDTI Innvierte, and Prous Institute for Biomedical Research. The funds will complete the ongoing Phase IIa trial of CTH120 in Fragile X syndrome, with preliminary results expected in mid-2027.

Minoryx Therapeutics, a member of Catalonia.health, and the Neuraxpharm Group have announced the completion of recruitment for the global Phase 3 CALYX clinical trial, which is evaluating leriglitazone (NEZGLYAL®) in adult male patients with cerebral adrenoleukodystrophy (cALD), a rare neurodegenerative disease with no approved pharmacological treatment options.

La firma de capital risc Asabys Partners, membre de Catalonia.health especialitzada en salut i ciències de la vida, participa com a co-líder en una ronda de finançament seed de 15 milions d'euros aixecada per iPremom, companyia de diagnòstic molecular dedicada a la predicció precoç de complicacions de l'embaràs.

Eurecat, with Connecthink, is taking part in the PROBIO-AI project to digitalise operational knowledge at EMLIFE Biotics using explainable, governed AI. The goal is to cut operational information access time by up to 60% and increase productivity by 30 to 40%.

Catalonia.health took part in the first Future Skills Observatory Workshop of the BRIGHTskills project, held on 29 June at IESE Business School in Barcelona.

Barcelona, ​​July 23, 2025 – As a partner of the European project RISEMED4EU (Regional Innovation for Smart Ecosystems in Health and Medicine in the EU), Catalonia.health has organized the third semester stakeholder meeting, held online.

Catalonia.health has celebrated Committee Day, the face-to-face meeting in which the association's five working groups (Innovation, Digital, Shared Value, Talent and Business Development) meet to take stock of the year and define the priorities for the coming year. The meeting took place on July 7 at the Barcelona Science Park.

The second vice-president of Catalonia.health and director of GoodGut (HIPRA), Mariona Serra-Pagès, participated last week in the conference "CIMTI Connect: From innovation to adoption", organized by the Center for Medical and Digital Innovation and Technology of Catalonia (CIMTI), which brought together more than 60 professionals from the country's health innovation ecosystem.

Onalabs, a Catalonia.health member company specialising in the digital monitoring of metabolic biomarkers through sweat, has closed a €9.3 million investment round that will strengthen its financial position and accelerate the commercial rollout of its business lines.

Barcelona, ​​July 2026 – Catalonia.health has completed the first edition of the IMPULS program, a business growth initiative for health companies developed with the support of ACCIÓ.

On July 7, Tech Barcelona's headquarters hosted a new training capsule from I4KIDS, the pediatric innovation hub coordinated by Hospital Sant Joan de Déu, organized in collaboration with Catalonia.health. The session brought together startup leaders, researchers and health professionals to discuss financing, regulation and international expansion in the field of pediatric health.

The company, a member of Catalonia.health, has obtained the CE marking for its surgical robotic system, a milestone that opens the door to its commercialization on the European market and marks the beginning of a new stage of growth.

The Catalonia.health barbecue celebrates its eleventh edition with 600 attendees and reaffirms itself as the networking space for Catalonia's health ecosystem

fetaLife Technologies, a spin-off created in 2025 by Hospital Clínic de Barcelona, ​​Hospital Sant Joan de Déu and the University of Barcelona, ​​a member of Catalonia.health, promotes the transfer to clinical practice of a disruptive technology aimed at improving survival and reducing the sequelae of extremely premature babies.

WIVI Vision, member of Catalonia.health, has achieved Class IIa health product certification for its visual therapy technology and has been selected by ACCIÓ as one of the ten companies in the Catalonia Exponential Leaders 2026 program.

The technology company IMAGINAE, a member of Catalonia.health, will participate as a technology partner in the NAIVE (Neotropical AI-assisted Vertebrate identification through ZooMS) project led by ICTA-UAB and scientifically directed by Dr. André Carlo Colonese, director of research at the Department of Prehistory and ICTA-UAB.

The HIPRA group, member of Catalonia.health, closed the 2025 financial year with a turnover of 516 million euros and a net profit of 53.9 million euros. The turnover represents an increase of 17% compared to the previous year and represents the highest annual turnover achieved by the group to date, consolidating its trajectory of growth and international expansion.

The Germans Trias i Pujol Research Institute (IGTP), member of Catalonia.health, celebrated on June 18 a new edition of the Innomed Awards, a day aimed at promoting biomedical innovation projects and strengthening the connection between research, the health system, entrepreneurship and investment. The event took place in the auditorium of the Josep Carreras Institute (IJC) on the Can Ruti Campus and brought together professionals from research, health, entrepreneurship and investment.